Dr. Mohamed AlAmeri

Dr. Mohamed currently serves as Advisor for Strategic Initiatives at the National Projects Office within Presidential Affairs and as Advisor to the Emirates Genome Council. Through these roles, he supports the advancement of high-impact national priorities and strategic initiatives.
Previously, Dr. Mohamed served as Director of the Genome and Biobank Division at the Department of Health – Abu Dhabi, where he led the development and execution of the national genome strategy and oversaw major genome-related initiatives, including the Emirati Genome Project and the Abu Dhabi Biobank. His work focused on advancing the adoption of precision medicine, establishing the regulatory and operational frameworks for gene therapy, and strengthening Abu Dhabi’s position as a leader in genomic medicine. Dr. Mohamed is also an Adjunct Assistant Professor at Khalifa University, contributing to academic mentorship in genomics, precision medicine, and gene therapy. He advises various local and international initiatives, providing strategic guidance on national genome programs, biobanking, and translational research. Earlier in his career, he served as Section Head for Studies and Special Projects at the Department of Health and as a Medical Laboratory Technologist at Sheikh Khalifa Medical City, where his work included diagnosing hematological and oncological diseases, implementing advanced genomic technologies, and monitoring emerging infectious diseases. He has also served as a Teaching Associate in Cell and Gene Therapy, as well as Personalized Medicine and Novel Therapies, at University College London.
Dr. Mohamed is a member of the British Society of Genetic Medicine, the Association of Clinical Genomic Science, and the Cancer Genetics Group. He has coordinated international collaborations, including the International FTD Genomics Consortium, and contributed to global scientific events. Beyond his scientific and professional work, he has been actively involved in youth engagement and sustainability initiatives through Masdar’s Sustainability Youth Council, the COP26 UAE Youth Delegation, and the Emirates Global Youth Council. Dr. Mohamed holds a PhD in the Genetics and Epigenetics of Pediatric Leukemia and a Master’s degree in Cell and Gene Therapy from University College London, as well as a Bachelor of Science specializing in Genetics from the University of Western Ontario in Canada.